Cargando…
Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel
Anticancer drugs, such as paclitaxel (PTX), are indispensable for the treatment of a variety of malignancies. However, the application of most drugs is greatly limited by the low water solubility, poor permeability, or high efflux from cells. Nanoparticles have been widely investigated to enable dru...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International (MDPI)
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155358/ https://www.ncbi.nlm.nih.gov/pubmed/21845085 http://dx.doi.org/10.3390/ijms12074395 |
_version_ | 1782210113722908672 |
---|---|
author | Liu, Yongjin Zhang, Bin Yan, Bing |
author_facet | Liu, Yongjin Zhang, Bin Yan, Bing |
author_sort | Liu, Yongjin |
collection | PubMed |
description | Anticancer drugs, such as paclitaxel (PTX), are indispensable for the treatment of a variety of malignancies. However, the application of most drugs is greatly limited by the low water solubility, poor permeability, or high efflux from cells. Nanoparticles have been widely investigated to enable drug delivery due to their low toxicity, sustained drug release, molecular targeting, and additional therapeutic and imaging functions. This review takes paclitaxel as an example and compares different nanoparticle-based delivery systems for their effectiveness in cancer chemotherapy. |
format | Online Article Text |
id | pubmed-3155358 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2011 |
publisher | Molecular Diversity Preservation International (MDPI) |
record_format | MEDLINE/PubMed |
spelling | pubmed-31553582011-08-15 Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel Liu, Yongjin Zhang, Bin Yan, Bing Int J Mol Sci Review Anticancer drugs, such as paclitaxel (PTX), are indispensable for the treatment of a variety of malignancies. However, the application of most drugs is greatly limited by the low water solubility, poor permeability, or high efflux from cells. Nanoparticles have been widely investigated to enable drug delivery due to their low toxicity, sustained drug release, molecular targeting, and additional therapeutic and imaging functions. This review takes paclitaxel as an example and compares different nanoparticle-based delivery systems for their effectiveness in cancer chemotherapy. Molecular Diversity Preservation International (MDPI) 2011-07-07 /pmc/articles/PMC3155358/ /pubmed/21845085 http://dx.doi.org/10.3390/ijms12074395 Text en © 2011 by the authors; licensee MDPI, Basel, Switzerland. http://creativecommons.org/licenses/by/3.0 This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/). |
spellingShingle | Review Liu, Yongjin Zhang, Bin Yan, Bing Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel |
title | Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel |
title_full | Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel |
title_fullStr | Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel |
title_full_unstemmed | Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel |
title_short | Enabling Anticancer Therapeutics by Nanoparticle Carriers: The Delivery of Paclitaxel |
title_sort | enabling anticancer therapeutics by nanoparticle carriers: the delivery of paclitaxel |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155358/ https://www.ncbi.nlm.nih.gov/pubmed/21845085 http://dx.doi.org/10.3390/ijms12074395 |
work_keys_str_mv | AT liuyongjin enablinganticancertherapeuticsbynanoparticlecarriersthedeliveryofpaclitaxel AT zhangbin enablinganticancertherapeuticsbynanoparticlecarriersthedeliveryofpaclitaxel AT yanbing enablinganticancertherapeuticsbynanoparticlecarriersthedeliveryofpaclitaxel |